OC
GBT

Oppenheimer & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Oppenheimer & Co’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,764
Closed -$408K – 1489
2022
Q2 		$408K Buy
12,764
+1,015
+9% +$29.7K 0.01% 991
2022
Q1 		$407K Buy
11,749
+422
+4% +$12.6K 0.01% 1079
2021
Q4 		$332K Buy
+11,327
New +$351K 0.01% 1186
2021
Q3 		– Sell
-21,665
Closed -$759K – 1601
2021
Q2 		$759K Buy
21,665
+5,863
+37% +$229K 0.01% 857
2021
Q1 		$644K Sell
15,802
-13,226
-46% -$608K 0.01% 861
2020
Q4 		$1.26M Buy
29,028
+12,901
+80% +$636K 0.03% 570
2020
Q3 		$889K Sell
16,127
-2,895
-15% -$184K 0.02% 627
2020
Q2 		$1.2M Buy
19,022
+10,987
+137% +$754K 0.03% 509
2020
Q1 		$411K Sell
8,035
-3,966
-33% -$266K 0.01% 800
2019
Q4 		$954K Buy
12,001
+4,636
+63% +$275K 0.02% 639
2019
Q3 		$357K Sell
7,365
-3,865
-34% -$201K 0.01% 921
2019
Q2 		$591K Buy
11,230
+2,086
+23% +$120K 0.02% 750
2019
Q1 		$484K Sell
9,144
-5,526
-38% -$272K 0.01% 838
2018
Q4 		$602K Sell
14,670
-1,227
-8% -$46K 0.02% 677
2018
Q3 		$604K Buy
15,897
+3,700
+30% +$164K 0.02% 785
2018
Q2 		$552K Buy
12,197
+7,751
+174% +$353K 0.02% 826
2018
Q1 		$215K Buy
+4,446
New +$248K 0.01% 1188

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Oppenheimer & Co's GBT Position: Q3 2022 in Review

Oppenheimer & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 12,764 shares — an estimated $408K sold.

Oppenheimer & Co first reported a position in GBT in Q1 2018 and held it in 17 quarters. The position peaked at $1.26M in Q4 2020. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Oppenheimer & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 12,764 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $408K.
  • Oppenheimer & Co first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 17 quarters.
  • Oppenheimer & Co's Global Blood Therapeutics, Inc. position peaked at $1.26M in Q4 2020.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Oppenheimer & Co's 13F filing for Q3 2022, filed 14 Nov 2022.